Key Findings on Semaglutide and Eye Health

By Dr. Kevin -

 

Key Findings on Semaglutide and Eye Health

Recent research analyzed over 31,000 cases from the FDA’s adverse event database to see if GLP-1 medications—commonly used for weight loss and type 2 diabetes—are linked to vision-threatening complications.

The Main Takeaways

  • Higher Risk with Wegovy: While both drugs contain semaglutide, the study found a significantly stronger "disproportionality signal" (a higher intensity of reported cases) for Wegovy compared to Ozempic.

  • Demographic Factors: The risk appeared higher in men than in women.

  • Dose Dependency: The data suggests that higher doses (specifically those used for weight loss) might be more closely associated with these eye-related reports.

  • Not All GLP-1s Are Equal: Interestingly, other similar drugs like Tirzepatide (Mounjaro/Zepbound) and Rybelsus (the pill version of semaglutide) did not show this same risk signal.

What is Ischemic Optic Neuropathy (ION)?

ION occurs when blood flow to the optic nerve is interrupted, similar to a "stroke" of the eye. It is a rare condition, but because it can lead to permanent vision loss, researchers are monitoring these medications closely.

Why Is This Happening?

Researchers believe the risk may be specific to how semaglutide affects fluid shifts and vascular tone in the body. Other medications like Tirzepatide may actually help buffer these effects, which is why they didn't show the same risk in this study.

Important Note: This study looks at reported cases, not clinical trials. If you are taking these medications, you should not stop treatment without consulting your doctor. Regular eye exams remain a vital part of health maintenance for those on these therapies.

Comments

Post a Comment

Leave a Comment or Question:

Popular posts from this blog

IMPLANTABLE COLLAMER LENS APPEARS BETTER THAN LASIK OR PRK FOR MODERATE TO HIGH MYOPIC PATIENTS

By Dr. Kevin -
Image
http://www2.cochrane.org/reviews/en/ab007679.html The results of this review suggest that the implantable lens (ICL) is are safer than excimer laser (the laser used in PRK and LASIK) surgical correction for moderate to high myopia in the range of -6.0 to -20.0 D and ICL is preferred by patients. ICL surgery resulted in better corrected visual acuity, better contrast sensitivity, and improved patient satisfaction. ICL may also be considered in cases where the patient has more moderate near-sightedness (in the range of -3.00 to -6.00). My personal experience with ICL gives me a high level of confidence in this procedure and the surgeon with whom I co-manage. All patients I have seen have been 20/20 or better. One patient was in the -6.00 range and the others in the -10 range! I see very little side effects. For more information, feel free to our office at 480-812-2211.
Read more

RINSING YOUR CONTACT LENS CASE IS NOT ENOUGH

By Dr. Kevin -
Image
Removal of biofilm from contact lens storage cases -- Wu et al., 10.1167/iovs.10-5796 -- Investigative Ophthalmology & Visual Science It has been conventional wisdom amongst eye doctors that most infections related to contact lenses actually originate from the contact lens storage case. I usually recommend rinsing the case after use and filling with fresh solution. However, it appears that thoroughly rubbing the inside of the case with clean fingers helps remove most of the biofilm on which the bacteria grow. I also usually recommend replacing one's case on a regular basis. I am surprised how many new patients come into my office with grimy, dirty contact lens cases. According to this study: "digital rubbing and rinsing, and/or wiping the lens cases with tissue are recommended. Air-drying and recapping the lens case lids after use without any additional cleaning methods or the use of antimicrobial cases should be discouraged."
Read more